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ackground: In December 2019, Severe Acute Respiratory Syndrome Novel Coronavirus 2 (SARS-nCOV2) 
was identified as potential causative agent for COVID-19 in the Wuhan City of China. This disease spread 
around the whole globe, thus WHO declared it as a pandemic by March 11, 2020. Due to rapid mutation 
rate, lack of specific genomic knowledge and treatment modalities against this RNA based virus, world scientific 
community urges to work for vaccine production, treatments options and alternative remedies including eastern 
herbs as potential anti-viral agents.  
Methods: Olea europaea (Olive) was found highly beneficial on the basis of its previous therapeutic applications. 
So, in the current study, its five different compounds (Catechin, Cynaroside, Elenolic Acid, Hydroxytyrosol, and 
Oleuropein) were chosen according to Lipinski physiochemical parameters, which were compared with already 
clinically used five anti-viral drugs (Ribavirin, Niclosamide, Nelfinavir, S-Nitroso-N-acetyl penicillamine, 
Chloroquine) against the Main-Peptidase (PDB ID:2GTB) of SARS-nCoV2 using Molecular Operating 
Environment (MOE) software.  
Results: Among the chosen compounds of Olea europaea which were docked on the active site of Main-
Peptidase, Oleuropein provide the best minimum binding energy of -8.3201kcal/mol followed by Cynaroside with 
-7.2121kcal/mol. These two energy complexes are considered to have better drug potential in this initial studies 
as compare to the already commercially used drug agents e.g. Chloroquine, Ribavirin, Niclosamide and S-
Nitroso-N-acetyl Penicillamine having binding energy of -6.7168, -5.8171, -6.3361 and -5.4219kcal/mol 
respectively. Other three agents from olive were also docked to compare the binding energy of aforementioned 
clinically used drugs.  
Conclusion: Oleuropein and Cynaroside are considered to be the most compelling compounds as a drug agent 
against coronavirus2 infection. Further, molecular dynamic simulations and in-vivo investigations are needed to 
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Introduction  
Rapid outbreak of respiratory disease in China caused 
nearly 1,016,395 worldwide deaths which posed serious 
public health issue [1]. Then in December 2019, Center 
for Disease Control and Prevention (CDC), Atlanta 
investigated and confirmed that a novel disease like 
pneumonia was caused by a novel coronavirus which 
was later, named SARS-nCoV2. This virus outbreak was 
originated in Wuhan city [2]. Due to its transmissible 
characteristics, it spread across 216 countries and 
territories around the world have reported 49,035,014 
confirmed cases of the coronavirus globally. On March 
11, WHO declared it as a pandemic disease. Then efforts 
were begun to find a productive treatment against 
Coronavirus Disease 2019 (COVID-19). Even after lots 
of efforts, no effective drugs were found, so scientists 
moved on to some natural herbs that have been used as 
traditional remedies since centuries. So, Olea europaea 
(Olive) plants was chosen here as a traditional remedy 
to check its efficacy against novel coronavirus, which 
have remarkable compounds named Catechin, 
Cynaroside, Oleuropein, Elenolic acid and 
Hydroxytyrosol. They have diversity of crucial 
therapeutic benefits such as antioxidant [3], cardio 
protective [4] and hypoglycaemic effect [5]. Previous 
investigations reported the therapeutic effects of Olea 
europaea against SARS-nCoV2 and provide clues for 
further investigations on other herbs such as Nigella 
sativa which is also considered effective against SARS-
nCoV2 [6]. Molecular docking of Olea europaea 
compounds were done against Main-Peptidase protein 
of coronavirus2 (PDB ID: 2GTB) and also compared with 
commercially used anti-viral drugs to check the drug 
efficacy of olive compounds against the COVID-19 
spread. This study was performed by Molecular 
Operating Environment (MOE) software [7]. 
Methods 
Potential drug agents and target protein retrieval 
Olea europaea was studied as a curative herb choice 
and its selected compounds such as Cynaroside, 
Elenolic Acid, Hydroxytyrosol, Catechin and Oleuropein 
retrieved from PubChem 
(https://pubchem.ncbi.nlm.nih.gov/) (Fig. 1), that were 
also reviewed from the literature according to Lipinski’s 
physiochemical parameters (Table 1) [8,9] to predict 
their drug potential properties. Their 3D structures were 
prepared by using ChemDraw 7.0.3. Similarly, selected 
target protein is the Main Peptidase of SARS-nCoV2 as 
it plays an essential role in the synthesis of RNA 
dependent RNA polymerase and helicase due to which 
it acts as an attractive and potential target for molecular 
docking [10]. The structure of Main Peptidase was 
obtained from Protein Data Bank (PDB) 
(https://www.rcsb.org/). Other clinically used drugs were 
also selected according to Lipinski’s rule of five and their 
chemical structure are shown (Fig. 2, Table 2) [11,12]. 
Molecular Operating Environment (MOE) software 
The molecular docking analysis was performed by MOE 
software v.2015.10. [7] to obtain binding energies scores 
of the complexes. MOE searches the best binding sites 
between the ligand and targeted macromolecules in 3D 
docking boxes [13]. All the parameters were performed 
by default application on 64GB with 5 core CPUs in 
Windows 10 Operating System. 
 













Catechin 290.27 g/mol 5 6 110 0.4 
Cynaroside 488.4 g/mol 7 11 186 0.5 
Elenolic Acid 242 g/mol 1 6 89.9 0.4 
Hydroxytyrosol 154.1 g/mol 3 3 60.7 -0.7 
Oleuropein 5404.4 g/mol 6 13 202 -0.4 
Table 1: Physiological properties of compounds of Olea europaea 
according to Lipinski’s Rule. 
 
 













Ribavirin 244.2 g/mol 4 7 -1.8 144 17 
Niclosamide 327.12 g/mol 2 4 4 95.21 21 
Nelfinavir 567.8 g/mol 4 6 5.7 127 40 
S-Nitroso-N acetyl 
penicillamine 
220.25 g/mol 2 6 -0.3 121 14 
Chloroquine 319.9 g/mol 1 3 4.6 28.2 22 
Table 2: Properties of clinically used anti-viral drugs according to 
Lipinski’s rule of five. 
Protein/Enzyme PDB 
ID 










Table 3: Crystalline properties of the Main-Peptidase protein of 
coronavirus.
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Preparation of ligand  
The structure of Cynaroside and other compounds were 
obtained from PubChem 
(https://pubchem.ncbi.nlm.nih.gov/) database. Ligand 
was prepared by MOE using canonical structure. Partial 
charges on the ligand molecule were applied and saved 
in .mdb format. 
Preparation of protein 
The structure of the Main-Peptidase cleavage protein of 
coronavirus was retrieved from PDB. Crystalline 
properties of the selected protein are mentioned in 
(Table 3). For the preparation, the sequence of a protein 
was edited to remove the water molecules and other 
ligand attached to the protein. 
3D Protonation of protein 
3D protonation is the inclusion of proton into a molecule, 
atom and ion. Although, 3D protonation changes the 
charges of the molecule up to one unit but some time it 
is unaffected during hydrogenation. 3D protonation 
exists in a wide variety of catalytic reactions that’s why 
3D protonation before molecular docking was used 
because certain residues and small molecules would be 
ionized under experimental conditions. Main-Peptidase 
protein molecule was prepared by 3D protonation while 
other factors such as temperature, pH, and salt remained 
constant according to the software default settings.  
Identifications of protein active site 
An active site or binding pocket of a protein is identified 
by the Site Finder tool of MOE software [14]. This method 
is energy-based for the prediction of active sites of a 
protein molecule. 
Molecular docking run  
Ligand-protein run was performed by MOE after 
preparation of our ligand and protein molecules. For 
docking run, select the Dock option, run the docking 
process by keeping all other parameters constant, then 
select the dummy atom from the site and choose .mdb 
ligand file. After successful docking of proteins and all 
compounds, their 2D & 3D interactions and binding 
energies were calculated. 
Results 
Main-Peptidase protein of SARS-nCoV2 was docked 
with five different compounds (Catechin, Cynaroside, 
Elenolic Acid, Hydroxytyrosol, Oleuropein) of Olea 
europaea. The target protein was prepared by 3D 
protonation and then used as a template for docking. The 
main active sites of protein residue were identified by the 
Site Finder feature of MOE software e.g. THR2, THR26, 
LEU27, HIS41, CYS44, MET49, PRO52, TYR54, 
PHE140. Different binding energies/docking score and 
root-mean-square deviation (RMSD) values of the 
complexes are determined which show the interaction 
potential, stability of our complexes and average 
distance between the atoms of our targeted protein 
respectively (Table 4). 
The data from binding energies showed that the 
compounds of Olea europaea have some very promising 
energy complexes, for instance, two of our tested 
Oleuropein and Cynaroside complexes with our targeted 
protein of Main-Peptidase gave the energy values of -
8.3201 and -7.2121 Kcal/mol which are even better than 
the energy values of clinically used anti-viral drugs of 
Niclosamide, Chloroquine, Ribavirin and Nelfinavir with -
6.3361, -6.1768, -5.8171 and -5.4219Kcal/mol 
respectively. Similarly, our other two tested complexes of 
Catechin and Elenolic Acid gave -6.0237 and -5.4360 
Kcal/mol energies which are better than clinically used 
anti-viral drugs of Ribavirin and S-Nitroso-N-acetyl 
penicillamine with -5.8171 and -5.4219Kcal/mol energies 
respectively. Docking scores of our five tested 
complexes and their comparison with clinically used 
drugs are given in (Table 5). 
Compounds Docking Score RMSD Value 
Oleuropein -8.3201 2.5832 
Cynaroside -7.2121 1.5454 
Catechin -6.0237 3.3014 
Elenolic Acid -5.4360 1.3060 
Hydroxytyrosol -4.5463 0.9260 




Score Already used Drugs Score 
Oleuropein -8.3201 Nelfinavir -8.4625 
Cynaroside -7.2121 Niclosamide -6.3361 
Catechin -6.0237 Chloroquine -6.1768 
Elenolic Acid -5.4360 Ribavirin -5.8171 
Hydroxytyrosol -4.5463 S-Nitroso-N-acetyl 
penicillamine 
-5.4219 
Table 5: Comparison between clinically used drugs and 
compounds of Olea europaea. 
 
Figure 3: 2-Dimensional & 3-Dimensional structure complexes of 
five compounds from Olea Europaea and five other clinically used 
anti-viral drugs. 
Discussion 
COVID-19 has affected the human population all around 
the world and appeared as great threat to global health. 
Although, there is no drug/vaccine has been accepted till 
date but endeavours are being made in different domains 
of medicines including allopathic, homeopathic, herbal 
and biologics fields. Plants are considered to be one of 
the great reservoirs for searching potential drug agents 
during this era of current pandemic [15]. So, Olea 
europaea plant was chosen to study as a potential drug 
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against this infection. Various aforementioned 
compounds of Olea europaea were selected according 
to the Lipinski’s physiochemical properties and they were 
docked with the Main-Peptidase of coronavirus by using 
MOE Software. Secondly, aforementioned clinically used 
drug agents were also docked to Main-Peptidase of 
coronavirus. The obtained scores were compared with 
clinically used anti-viral drugs which showed very 
promising results and this plant have the potential to 
serve as a first shield against corona virus infections until 
the production, efficacy and acceptance of its potential 
vaccine.   
Our results are endorsed with many of the previous 
studies where olive compounds are beneficial in many 
diseases including COVID-19 [16-18]. This hypothesis 
still needs further molecular dynamic simulations studies 
and in-vivo animal and human trials for validation against 
the existing peril of COVID-19.  
Purpose of this study is to check the inhibitory effects 
of the Olea europaea compounds as drug agent with 
therapeutic effects on the Main-Peptidase of SARS-
nCoV2. We found that Oleuropein and Cynaroside have 
the lowest energy binding complex as compared to 
marketed anti-viral drug agents. Therefore, we assume 
that usage of olive which contains Oleuropein and 
Cynaroside may help to reduce the infection of SARS-
nCoV2. However, further in-vitro and in-vivo studies are 
still needed to validate this hypothesis which is 
postulated through this initial computer aided prediction 
of aforementioned compounds as potential drug. 
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